Robustness of Serologic Investigations for Chikungunya and Mayaro Viruses following Coemergenceby Fischer et al.
In this study the authors' data provide a convenient and practicable solution to ensure robust differentiation of CHIKV- and MAYV-specific antibodies.
5th February 2020 • comment
ClearColi BL21(DE3)-based expression of Zika virus antigens illustrates a rapid method of antibody production against emerging pathogensby Viranaicken et al.
The remarkable efficacy of the ClearColi BL21(DE3)-based expression system at eliciting the rapid production of specific anti-ZIKV antibodies endorses an innovative method, which can be extended to emerging viruses for which development of immunological tools is an urgent prerequisite.
12th October 2017 • comment